[go: up one dir, main page]

HK1076816A1 - 2,4-diamino-1,3,5-triazine derivative - Google Patents

2,4-diamino-1,3,5-triazine derivative Download PDF

Info

Publication number
HK1076816A1
HK1076816A1 HK05111431.9A HK05111431A HK1076816A1 HK 1076816 A1 HK1076816 A1 HK 1076816A1 HK 05111431 A HK05111431 A HK 05111431A HK 1076816 A1 HK1076816 A1 HK 1076816A1
Authority
HK
Hong Kong
Prior art keywords
group
reduced pressure
under reduced
mixture
solvent
Prior art date
Application number
HK05111431.9A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1076816B (en
Inventor
Shiro Maeda
Toshiko Kita
Kanji Meguro
Original Assignee
Hamari Chemicals, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals, Ltd. filed Critical Hamari Chemicals, Ltd.
Publication of HK1076816A1 publication Critical patent/HK1076816A1/en
Publication of HK1076816B publication Critical patent/HK1076816B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK05111431.9A 2002-12-17 2003-12-16 2,4-diamino-1,3,5-triazine derivative HK1076816B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002365927 2002-12-17
JP2002-365927 2002-12-17
JP2003363820 2003-10-23
JP2003-363820 2003-10-23
PCT/JP2003/016131 WO2004054989A1 (ja) 2002-12-17 2003-12-16 新規２，４−ジアミノ−１，３，５−トリアジン誘導体

Publications (2)

Publication Number Publication Date
HK1076816A1 true HK1076816A1 (en) 2006-01-27
HK1076816B HK1076816B (en) 2013-10-25

Family

ID=

Also Published As

Publication number Publication date
CA2510468C (en) 2011-01-04
EP1574503B1 (en) 2013-03-13
MXPA05006450A (es) 2005-08-19
ES2403141T8 (es) 2013-06-21
ES2403141T3 (es) 2013-05-14
KR101027366B1 (ko) 2011-04-11
JP4391422B2 (ja) 2009-12-24
BRPI0317188A8 (pt) 2018-05-08
AU2003289375A1 (en) 2004-07-09
CA2510468A1 (en) 2004-07-01
JPWO2004054989A1 (ja) 2006-04-20
EP1574503A1 (en) 2005-09-14
US20060154928A1 (en) 2006-07-13
EP1574503A4 (en) 2008-06-25
NZ540972A (en) 2009-03-31
WO2004054989A1 (ja) 2004-07-01
US7622469B2 (en) 2009-11-24
KR20050085720A (ko) 2005-08-29
BRPI0317188A2 (pt) 2005-11-01

Similar Documents

Publication Publication Date Title
EP1574503B1 (en) 2,4-Diamino-1,3,5-triazine derivative
US7034021B2 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
US5358960A (en) Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles
EP0037224A1 (en) Rare earth metal carboxylates, their use as antimicrobial agents, and medicinal, cosmetic and cleansing compositions containing them
CN110868991A (zh) 包含锌：地衣酸络合物的个人护理组合物及使用方法
EP4446313A1 (en) Hydrate crystal of 5-chloro-4-(3-chloro-4-methylphenyl)-1h-imidazole-2-carbonitrile
US6458819B1 (en) Thiazolium compounds and treatments of disorders associated with protein aging
WO1995013057A1 (fr) Procede antimicrobien et composition cosmetique
US2837463A (en) Therapeutic compositions comprising 5-amino hexahydropyrimidines or salts thereof
HK1076816B (en) 2,4-diamino-1,3,5-triazine derivative
JPH07138155A (ja) 抗微生物剤
KR101068533B1 (ko) 탈모 방지 및 발모 촉진용 화합물로서의 인돌-3-아세트산, 이를 포함하는 나노하이브리드 복합체 및 발모 촉진용 조성물
CN100551916C (zh) 新的2,4-二氨基-1,3,5-三嗪衍生物
EP0839030A2 (en) Bis- hydrazones]
JPH05194361A (ja) モノビグアナイド誘導体とこの誘導体を含有した消毒薬
EP2332925A1 (en) Novel dihydrotriazine derivative
US4098879A (en) N-alkyl-3-pyridinium-methanol fluorides and derivatives thereof
CA3181160A1 (en) Antifungal agent for human
USRE30309E (en) N-Alkyl-3-pyridinium-methanol fluorides and derivatives thereof
WO2008110351A2 (en) Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents
EP0889884B1 (en) 1,2,4-triazine derivatives for the inhibition of protein glycosylation
HK1007310A1 (en) Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives
GB1575915A (en) Pyridine derived fluorides and pharmaceutical compositions containing them
HK1007310B (en) Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20231215